Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - COVID-19 Prevention
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Renal Transplant Maintenance
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Wet AMD
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - COPD
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Psoriatic Arthritis
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Urology
  - BACK
  - Urology
  - Uncomplicated Urinary Tract Infections
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

expert roundtables

High-Risk MDS and AML: Present Strategies and Future Directions

High-Risk MDS and AML: Present Strategies and Future Directions

expert roundtables
By David Sallman, MD; Guillermo Garcia-Manero, MD; Harry Paul Erba, MD, PhD

Effective Triplets for Nontransplant Patients With Multiple Myeloma

Effective Triplets for Nontransplant Patients With Multiple Myeloma

expert roundtables
By Kenneth C. Anderson, MD; S. Vincent Rajkumar, MD; Sagar Lonial, MD, FACP, FASCO

$Review of Recent Approvals for Relapsed/Refractory Multiple Myeloma$

Review of Recent Approvals for Relapsed/Refractory Multiple Myeloma

expert roundtables
By Kenneth C. Anderson, MD; S. Vincent Rajkumar, MD; Sagar Lonial, MD, FACP, FASCO

Advancements in the Risk-Adapted Treatment of Mantle Cell Lymphoma

Advancements in the Risk-Adapted Treatment of Mantle Cell Lymphoma

expert roundtables
By Brad Kahl, MD; John M. Pagel, MD, PhD; John P. Leonard, MD

Research Perspectives: Chemotherapy-Free Initial Therapy for Older Patients With Mantle Cell Lymphoma

Research Perspectives: Chemotherapy-Free Initial Therapy for Older Patients With Mantle Cell Lymphoma

expert roundtables
By Brad Kahl, MD; John M. Pagel, MD, PhD; John P. Leonard, MD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?